Document:

Exhibit 10.1

 

 

 

EMPLOYMENT AGREEMENT

 

This Employment
Agreement (this “Agreement”) is entered into effective January 27, 2021 (the “Effective
Date”), by Anna Lucsok (“Executive”)
and Zynex Medical (the “Company”).

 

RECITALS

 

		A.	Company desires to hire Executive as Chief Operating Officer and to compensate Executive for Executive’s
services to the Company; and

 

		B.	Executive wishes to be employed by the Company and provide services to the Company in return for
certain compensation; and

 

		C.	WHEREAS, the Company and Executive desire to enter into this Agreement

 

Accordingly, in consideration of the mutual
promises and covenants contained in this Agreement and for other good and valuable consideration, the sufficiency of which is acknowledged,
the parties agree to the following:

 

1.            Definitions.

 

		1.1	“Affiliates” means, with respect to the Company, any entity which, directly
or indirectly, is controlled by or is under common control with the Company

 

1.2            “Board
of Directors” or “Board” means the Board of Directors of the Company.

 

1.3            “Cause”
will be limited to mean the following:

 

		(i)	Willful misfeasance or nonfeasance by Executive that materially injures the reputation, business
or business relationships of the Company or its Affiliates, or any of their respective officers, directors or employees and such
action or failure is not remedied or reasonable steps to effect such remedy are not commenced within thirty (30) days following
receipt of written notice;

		(ii)	Any act involving moral turpitude or conviction of a crime other reflects in some material fashion
unfavorably upon the business or business relationships of the Company, its Affiliates, or any of its officers, directors or employees;

		(iii)	The willful and continued failure to perform substantially the Executive’s duties or to follow
the reasonable direction of the CEO or the Board within thirty (30) business days after receipt by Executive of written notice
of such failure, other than by reason of Disability (as defined below) or approved leave of absence; or

		(iv)	Willful or prolonged absence from work by Executive, other than by reason of Disability or approved
leave of absence, whether paid or unpaid.

 

		1.4	“Code” will mean the Internal Revenue Code of 1986, as amended from time
to time, and the regulations promulgated thereunder.

 

		1.5	“Disability” will mean the earliest of the date on which Executive is
deemed disabled under: (i) the long-term disability policy maintained by the Company; (ii) Code Section 22(e)(3);
or (iii) the determination of the Social Security Administration. Notwithstanding the foregoing, Executive will not be considered
to have suffered a Disability under subparagraph (ii) above if Executive timely provides medical certification from a qualified
licensed physician that Executive is able to perform the essential functions of Executive’s position, with or without reasonable
accommodation.

 

     

     

    

 

		1.6	“Good Reason” will mean the occurrence of any of the following without
Executive’s prior written consent:

 

		(i)	the removal of Executive as Chief Operating Officer of the Company, assignment to Executive of
any duties or responsibilities materially inconsistent with Executive’s position, including any material diminution of Executive’s
status, title, authority, duties or responsibilities or any other action that results in a material diminution in such status,
title, authority, duties or responsibilities;

		(ii)	the reduction by five percent (5%) or more of Executive’s base salary or the reduction by
five percent (5%) or more of the aggregate of Executive’s base salary and Incentive Compensation target cumulatively during
any one year period, without Executive’s consent, or any action that materially adversely affects Executive’s overall
compensation and benefits package, provided that the Company may change the benefits package if those changes are made on a non-discriminatory
basis for all employees who participate in the benefits plans available to Executive; or

		(iii)	the failure of the Company to pay to Executive any portion or installment of any salary, Incentive
Compensation or deferred compensation within fifteen (15) days of the date such compensation is due.

 

		1.7	“Termination Date” will mean Executive’s
last day of employment, regardless of whether termination is on account of death, Disability, with or without Cause, or a resignation
with or without Good Reason.

 

2.            Employment
by the Company.

 

		2.1	Position. Subject to the terms set
forth in this Agreement, the Company agrees to employ Executive in the position of Chief Operating Officer and Executive hereby
accepts such employment and position. During the term of Executive’s employment with the Company, Executive will devote Executive’s
best efforts and substantially all of Executive’s business time and attention to the business of the Company.

 

		2.2	Duties. Executive will report to the
CEO and will perform such duties as are normally associated with Executive’s position as are assigned to Executive from time
to time. Executive will perform Executive’s duties under this Agreement at the Company’s principal place of business
and such other locations as agreed upon by Executive and the Company.

 

		2.3	Term. The term of this Agreement will
run from the Effective Date until such time as it is terminated in accordance with the terms of this Agreement.

 

		2.4	Company Policies and Benefits. The
employment relationship between the parties will be subject to the Company’s personnel policies and procedures as they may
be adopted, revised or deleted from time to time in the Company’s sole discretion. Subject to any specific exceptions or
conditions set forth in Section 3.5, Executive will be eligible to participate on substantially the same basis as similarly
situated Executives in the Company’s benefit plans and programs in effect from time to time during Executive’s employment;
provided, however, that participation and awards under any equity compensation or equity Incentive Compensation plan or
program will be determined by the Board on an individual, case-by-case basis. All matters of eligibility for coverage or benefits
under any benefit plan or program will be determined in accordance with the provisions of such plan or program. The Company reserves
the right to change, alter, or terminate any benefit plan or program in its sole discretion; provided, however, that
no such change, alteration or termination will change any vested or accrued benefits or rights of Executive. Notwithstanding the
foregoing, in the event that the terms of this Agreement expressly provide Executive with benefits that differ from the Company’s
generally available benefits, then the terms of this Agreement will control.

 

Compensation
and Benefits.

 

		2.5	Salary. Executive will receive for
Executive’s services to be rendered under this Agreement an initial annualized base salary of $200,000 (the “Base
Salary”), subject to annual review and adjustment from time to time by the CEO. The Base Salary will be payable in
accordance with Company’s standard payroll practices.

 

     

     

    

 

		2.6	Stock Grants. Executive will receive
50,000 restricted shares on the date this agreement is executed. These shares vest over four years, at a rate of 25% per year.
Executive will also receive ongoing quarterly grants of 5,000 restricted shares that also vest over four years, at a rate of 25%
per year.

 

		2.7	Incentive Compensation. Executive will
be eligible for quarterly incentive compensation (“Incentive Compensation”) in the total amount of $200,000
per calendar year, as determined by the CEO based on an incentive compensation plan to be established annually in writing by
the Board. The Incentive Compensation will be calculated based on performance goals measured at the end of the applicable quarter.
The Company will pay earned quarterly Incentive Compensation at the time(s) determined by the Company, but in no event later
than 15 days after when the Company’s financial results are published following the quarter in which Executive’s right
to the Incentive Compensation arises. In addition to the cash incentive compensation, Executive will be eligible to earn restricted
stock on a quarterly basis up to a value of $100,000 per year, based on the same performance metrics.

 

		2.8	Expense Reimbursement. The Company
will reimburse Executive for reasonable business expenses incurred by Executive during the period Executive is employed by the
Company, in accordance with the Company’s standard expense reimbursement policy.

 

		2.9	Paid Time Off. Executive will have
paid time off in accordance with Company policy.

 

		2.10	Benefits  As provided in Section 2.4,
Executive will receive benefits in accordance with the Company’s standard benefits plan and policies, as amended from time
to time.

 

		3.	Non-Competition; Non-Solicitation; Confidentiality.

 

		3.1	Non-Competition. Executive acknowledges
that Executive will gain extensive and valuable experiences and knowledge in the business conducted by the Company and its Affiliates
and will have extensive contacts with customers of the Company and its Affiliates. Accordingly, in consideration of the mutual
promises contained in this Agreement, Executive covenants and agrees with the Company that, during the term of this Agreement and
for the Applicable Severance Payout Period (as defined in Section 7.2(c) following the Executive’s Termination
Date, Executive will not compete directly or indirectly with the Company or its Affiliates and will not during such period make
public statements in derogation of the Company or its Affiliates. Competing directly or indirectly with the Company and its Affiliates
will mean engaging or having a material interest, directly or indirectly, as owner, employee, officer, director, partner, venturer,
stockholder, capital investor, consultant, agent, principal, advisor or otherwise, either alone or in association with others,
in the operation of any entity’s division or group which manufactures and markets medical devices that treat chronic and
acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. Competing directly
or indirectly with the Company or its Affiliates, as used in this Agreement, will not include having an ownership interest as an
inactive investor, which for purposes of this Agreement will mean the beneficial ownership of less than five percent (5%) of the
outstanding shares of any series or class of securities of any competitor of the Company, which shares are publicly traded in the
securities markets. This Section 4.1 will cease to apply in the event the Company is in breach of any obligations to
provide severance benefits in accordance with Section 7.2 and fails to cure such breach within twenty (20) days of
receiving written notice of such breach from Executive. Executive agrees that any violation of this Section 4.1 by
Executive, as determined by a court of law, will result in termination of the Company’s obligations to provide severance
benefits under this Agreement and in the event of such termination, Executive will be required to repay to the Company any such
severance benefits previously received.

 

     

     

    

 

		3.2	Non-Solicitation. Executive
acknowledges that Executive will have extensive contacts with employees and customers of the Company. Accordingly, in consideration
of the mutual promises contained in this Agreement, Executive covenants and agrees that during the term of this Agreement, and
for the Applicable Severance Payout Period following Executive’s Termination Date, Executive will not (i) solicit, raid,
entice or induce any employee of the Company or its Affiliates to leave the employ of the Company or its Affiliates; (ii) interfere
with the relationship of the Company or its Affiliates with any such employees, including, but not limited to, hiring such employee;
or (iii) personally target or solicit customers of the Company or its Affiliates to purchase products or services in competition
with the Company’s or its Affiliates products or services or to terminate a relationship with the Company or its Affiliates.
This Section 4.2 will cease to apply in the event the Company is in breach of any obligations to provide severance
benefits in accordance with Section 7.2 and fails to cure such breach within twenty (20) days of receiving notice of
such breach from Executive. Executive agrees that any violation of this Section 4.2 by Executive, as determined by
a court of law, will result in termination of the Company’s obligations to provide severance benefits hereunder and in the
event of such termination, Executive will be required to repay to the Company any such severance benefits previously received.

 

		3.3	Confidentiality. Executive acknowledges
that Executive will have access to certain information related to the business, operations, future plans and customers of the Company
and its Affiliates, the disclosure or use of which could cause the Company substantial losses and damages. Accordingly, Executive
acknowledges and affirms the terms and conditions of the Confidentiality and Non-Compete Agreement signed by Executive, which is
incorporated by reference. The terms and conditions of Sections 4.1 and 4.2 will take precedence over any non-competition/non-solicitation
provisions contained in the Confidentiality and Non-Compete Agreement.

 

		4.	Outside Activities. Except with the
prior written consent of the CEO, Executive will not, while employed by the Company, undertake or engage in any other employment,
occupation, consulting, advisory, or other business enterprise or business activities that would interfere with Executive’s
responsibilities and the performance of Executive’s duties under this Agreement with the exception that engaging in charitable,
civic, community activities and serving of boards of directors of charitable or civic organizations will not constitute interference,
provided the time spent in such activities does not negatively impact Executive’s performance of Executive’s duties
under this Agreement.

 

		5.	No Conflict with Existing Obligations.
Executive represents that Executive’s performance of all the terms of this Agreement and as an executive of the Company does
not and will not breach any agreement or obligation of any kind made prior to Executive’s employment by the Company, including
agreements or obligations Executive may have with prior employers or entities for which Executive has provided services. Executive
has not entered into, and Executive agrees that Executive will not enter into, any agreement or obligation, either written or oral,
that conflicts with Executive’s obligations hereunder.

 

		6.	Termination of Employment. The parties
acknowledge that Executive’s employment relationship with the Company is at-will. Either Executive or the Company may terminate
the employment relationship at any time, with or without Cause. The provisions in this Section 7 govern the amount
of compensation, if any, to be provided to Executive upon termination of Executive’s employment and do not alter Executive’s
at-will status.

 

		6.1	Standard Termination Payments.

 

		a.	Salary and Reimbursements. Regardless of the
reason for termination, the Company will pay Executive on the first regularly scheduled payroll date following Executive’s
Termination Date any Base Salary accrued but unpaid as of Executive’s Termination Date, the value of any accrued paid time
off unused by Executive as of Executive’s Termination Date, and any unpaid Expense Reimbursement, so long as the Expense
Reimbursement complies with the Company guidelines for such requests.

 

		b.	Incentive Compensation. In the event Executive’s
employment with the Company terminates for any reason (including death or Disability) before the end of any quarterly or annual
performance period on which the Incentive Compensation is based, Executive will be paid a pro-rata portion of Executive’s
Incentive Compensation (based on the number of days Executive was employed in the applicable quarter with regard to the quarterly
Incentive Compensation and the number of days Executive was employed in the calendar year with respect to the annual Incentive
Compensation) of the Incentive Compensation that is earned for the quarter/year in which Executive’s employment with the
Company terminated, such amounts to be paid on the date the Company would otherwise have paid the Incentive Compensation if Executive’s
employment with the Company had not terminated. If the Incentive Compensation is considered “compensation” for purposes
of any Company-sponsored qualified retirement plan, the right to defer such Incentive Compensation will continue to be governed
by such plan or plans, with the terms of such plan or plans incorporated into this Agreement by reference.

 

     

     

    

 

		6.2	Severance Benefits ― Termination Without Cause/Resignation
For Good Reason.

 

		a.	Company’s Right to Terminate. The Company
will have the right to terminate Executive’s employment under this Agreement for any of the following reasons:

 

(i)            upon
Executive’s Disability in accordance with Section 7.5;

(ii)           for
Cause, by giving notice as described in Section 7.6;

(iii)          without
Cause.

 

		b.	Executive’s Right to Terminate. Executive
will have the right to resign Executive’s employment with the Company at any time, as well as following an event constituting
Good Reason.

 

		c.	Severance Benefits. In the event that the Company
terminates Executive’s employment without Cause or Executive resigns for Good Reason, Executive will receive, in addition
to the Standard Termination Payments, the following:

 

		(i)	Severance Payments. Provided that Executive delivers to the Company a fully executed
and complete release, without revocation, in favor of the Company and its Affiliates, and in form and substance satisfactory to
the Company (the “Release”) within thirty (30) days of Executive’s Termination Date (the “Execution
Deadline”), the Company will provide to Executive (a)  an amount equal to six (6) months of Executive’s
then-current Base Salary. The Severance Payments will be payable in equal installment payments over the six (6) month period
(“Applicable Severance Payout Period”) starting retroactively from the Termination Date in accordance with
the Company’s regular bi-weekly paydays, or if different, in accordance with the Company’s customary payroll practices.

 

		(ii)	COBRA Benefits. In the event Executive elects continuation coverage pursuant to the
Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) in accordance with the COBRA materials that will be
provided to Executive by the Company or the Company’s third party COBRA administrator, the Company will pay the Company’s
portion (based upon the Company’s monthly premium subsidy immediately prior to the Termination Date) of Executive’s
COBRA premium for the same medical, dental and vision benefit plan coverage (“Group Health Plan Coverage”)
Executive and Executive’s dependents had as of the Termination Date for the Applicable Severance Payout Period, or until
Executive elects to receive group medical, dental and vision insurance from another source, whichever occurs first. Payment of
COBRA premiums will be made by the Company on Executive’s behalf directly to the Group Health Plan’s COBRA administrator.
Executive will be mailed a COBRA packet at his last known address. Such packet will contain additional information about Executive’s
COBRA rights and responsibilities.

 

		(iii)	Severance Benefits Contingent on Execution of Release. Notwithstanding the foregoing,
any Severance Payments that are otherwise payable before the Execution Deadline will be withheld pending Executive’s execution
and delivery of the Release and will be paid on the payroll date immediately following the Execution Deadline. For the avoidance
of doubt, Executive will forfeit the right to receive any Severance Payments or COBRA Benefits if Executive fails to deliver the
Release by the Execution Deadline. For this forfeiture to take effect, the Release will not materially alter Executive’s
rights to receive any payments or benefits under this Agreement; enlarge Executive’s obligations under this Agreement, including
without limitation, Executive’s covenants of non-competition and non-solicitation; or impose material new obligations on
Executive.

 

     

     

    

 

		d.	Compliance with Code Section 409A. The
Company and Executive intend that (i) payments under Section 7.2(c)(i) will be made on account of an involuntary
separation from service within the meaning of Treasury Regulation section 1.409A-1(n)(1) or a separation from service for
good reason within the meaning of Treasury Regulation section 1.409A-1(n)(2), (ii) amounts paid under Section 7.2(c)(i) constitute
separation pay exempt from Internal Revenue Code Section 409A under Treasury Regulation section 1.409A-1(b)(9)(iii), and (iii) Payments
under Section 7.2(c)(ii) will be exempt from Code Section 409A as a non-taxable fringe benefit to Executive,
but neither party will be liable to the other in the event any such payment receives different tax treatment. In the event any
of these payments is determined to be deferred compensation subject to Internal Revenue Code Section 409A, the payments will
comply with Section 7.8.

 

		6.3	Termination Upon Death or Disability of Executive.

 

		a.	Upon Executive’s death while employed pursuant to this Agreement, this Agreement will automatically
terminate.

		b.	Subject to applicable state and federal law, the Company will at all times have the right, upon
thirty (30) days written notice to Executive, to terminate this Agreement based on Executive’s Disability.

		c.	In the event Executive’s employment is terminated due to Executive’s death or Disability,
the Company will pay to Executive or Executive’s heirs or estate all Standard Termination Payments together with any other
compensation and benefits payable to Executive through the Executive’s Termination Date under any compensation or benefit
plan, program or arrangement during such period. In addition, if Executive, or if Executive is deceased, a participant on Executive’s
health insurance plan, elects COBRA coverage, the Company will pay its third party administrator the full cost of COBRA coverage
for twelve (12) months from the Executive’s Termination Date.

 

		6.4	Notice; Effective Date of Termination.

 

		a.	Termination of Executive’s employment pursuant to this Agreement will be effective on the
earliest of:

 

		(i)	excluding a termination due to Executive’s death or Disability, the date on which the Company
gives notice to Executive of Executive’s termination, with or without Cause, unless the Company specifies a later date, in
which case, termination will be effective as of such later date;

		(ii)	the date of Executive’s death;

		(iii)	ten (10) days after the Company gives notice to Executive of Executive’s termination
on account of Executive’s Disability; or

		(iv)	thirty (30) days after Executive gives written notice to the Company of Executive’s resignation,
provided that the Company may set a termination date at any time between the date of notice and the 30th day
thereafter (i.e., the effective date of resignation, but for this Section 7.5(a)), in which case the Executive’s
resignation will be effective as of such earlier date (the date on which Executive’s resignation becomes effective, the “Actual
Resignation Effective Date”).

 

		b.	In the event that notice of a termination is given orally, at the other party’s request,
the party giving notice must provide written confirmation of such notice within five (5) business days of the request. In
the event of a termination for Cause, written confirmation will specify the subsection(s) of the definition of Cause being
relied on by the Company to support the decision to terminate for Cause, to afford Executive a reasonable opportunity to effect
a cure, if permitted and possible under the applicable subsections of the definition of Cause. In the event of a resignation for
Good Reason, written confirmation will specify the subsection(s) of the definition of Good Reason being relied on by Executive
to support the decision to resign for Good Reason, to afford the Company a reasonable opportunity to cure under the applicable
subsections of the definition of Good Reason.

 

     

     

    

 

		6.5	Cooperation With the Company After Termination of
Employment. Notwithstanding anything to the contrary contained herein, payment of the amounts specified in this
Agreement is conditional upon Executive reasonably cooperating with the Company in connection with all matters relating to Executive’s
employment with the Company, assisting the Company as reasonably requested in transitioning Executive’s responsibilities
to Executive’s replacement, and Executive being available to answer questions and provide transition assistance to the Company
through the end of the period during which Severance Benefits are to be paid. Following Executive’s Termination Date, such
assistance will be provided at mutually acceptable times, and in reasonable amounts, taking into account other commitments that
Executive may have. Executive agrees to use Executive’s best efforts to minimize any conflicts with other commitments to
facilitate this assistance. The Company agrees to reimburse Executive for reasonable out of pocket, pre-approved expenses incurred
in providing such assistance.

 

		6.6	Application of Section 280G. In
the event that it is determined that the Severance Benefit payable to Executive pursuant to Section 7 of this Agreement,
when added to any other payment or benefit to Executive from the Company that would be considered a “parachute payment”
(a “Parachute Payment”), within the meaning of section 280G of the Code, would cause Executive to be
considered to receive an “excess parachute payment” within the meaning of section 280G of the Code (an “Excess
Parachute Payment”), the amount payable to Executive pursuant to Section 7 of this Agreement will be
reduced to the maximum amount that, when added to any other Parachute Payments made to Executive, could be paid to Executive without
causing Executive to receive an Excess Parachute Payment. Notwithstanding the foregoing, the Severance Benefit payable to Executive
pursuant to Section 7 of this Agreement will not be reduced if (i) the net amount payable to Executive without
the reduction described in the preceding sentence, but reduced by all Federal, state and local income and employment taxes payable
by Executive on the Severance Benefit payable pursuant to this Agreement and all other Parachute Payments plus the excise tax payable
on the Excess Parachute Payment pursuant to Section 4999 of the Code, is greater than (ii) the net amount that would
be payable to Executive with the reduction described in the preceding sentence and reduced by all Federal, state and local income
and employment taxes payable by Executive on the Severance Benefit payable pursuant to this Agreement and all other Parachute Payments.
For purposes of this Section 7.7, Executive will be deemed to pay Federal income tax and employment taxes at the highest
marginal rate of Federal income and employment taxation in the calendar year in which the Excess Parachute Payment would occur
and state and local income taxes at the highest marginal rate of taxation in the state and locality of Executive’s residence
in the calendar year in which the Excess Parachute Payment would be made, net of the reduction in Federal income taxes that Executive
may obtain from the deduction of such state and local income taxes. In addition, all determinations to be made under this Section 7.7
will be made by the Company’s independent public accountant (the “Accounting Firm”) immediately
before the date the Severance Benefit under Section 7 is to be paid. The Accounting Firm will provide its determinations
and any supporting calculations and work papers both to the Company and to Executive within ten (10) days of such date, and
any such determination by the Accounting Firm will be binding upon the Company and Executive.

 

		6.7	Deferred Compensation Subject to Code Section 409A.
Notwithstanding anything to the contrary set forth herein, any payments and benefits provided under this Agreement that constitute
 “deferred compensation” within the meaning of Code Section 409A will not commence in connection with Executive’s
termination of employment unless and until Executive has also incurred a “separation from service” (as such term is
defined in Treasury Regulation Section 1.409A-1(h) (“Separation From Service”), unless the
Company reasonably determines that such amounts may be provided to Executive without causing Executive to incur additional tax
under Code Section 409A. It is intended that each installment of Severance Benefits provided for in this Agreement is a separate
 “payment” for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i). For the avoidance of doubt, it is intended
that Severance Benefits set forth in this Agreement satisfy, to the greatest extent possible, the exceptions from the application
of Section 409A provided under Treasury Regulation Sections 1.409A-1(b)(4), 1.409A-1(b)(5), and 1.409A-1(b)(9). If the Company
(or, if applicable, the successor entity thereto) determines that any payments or benefits constitute “deferred compensation”
under Code Section 409A and Executive is, on the termination of service, a “specified Executive” of the Company
or any successor entity thereto, as such term is defined in Section 409A(a)(2)(B)(i) of the Code, then, solely to the
extent necessary to avoid the incurrence of the adverse personal tax consequences to Executive under Section 409A, the timing
of the payments and benefits will be delayed until the earlier to occur of: (a) the date that is six (6) months and one
day after Executive’s Separation From Service, or (b) the date of Executive’s death (such applicable date, the
 “Specified Executive Initial Payment Date”). On the Specified Executive Initial Payment Date, the Company
(or the successor entity thereto, as applicable) will (i) pay to Executive a lump sum amount equal to the sum of the payments
and benefits that Executive would otherwise have received through the Specified Executive Initial Payment Date if the commencement
of the payment of such amounts had not been so delayed pursuant to this Section 7.8 and (ii) commence paying the
balance of the payments and benefits in accordance with the applicable payment schedules set forth in this Agreement.

 

     

     

    

 

		7.	General Provisions.

 

		7.1	Notices. Any notice required or permitted
under this Agreement will be given in writing by delivery in hand, express courier or by postage prepaid, United States first class
mail; registered or certified mail, return receipt requested; facsimile at the party’s specified address; or as otherwise
specified by a party. Notice will be effective upon receipt.

 

		7.2	Right To Injunctive Relief. Executive
agrees and acknowledges that a violation of the covenants contained in Section 4 of this Agreement will cause irreparable
damage to the Company, and that it is and will be impossible to estimate or determine the damage that will be suffered by the Company
in the event of breach by Executive of any such covenant. Therefore, Executive further agrees that, in the event of any violation
or threatened violation of such covenants, the Company will be entitled to an injunction issued by any court of competent jurisdiction
restraining such violation or threatened violation by Executive, such right to an injunction to be cumulative and in addition to
whatever other remedies the Company may have.

 

		7.3	Partial Invalidity/Severability/No Amendment Of Existing
Agreements. Executive acknowledges that the periods of time and geographic area of restrictions imposed by Section 4
are fair and reasonable and are reasonably required for the protection of the Company. If any part or parts of Section 4
will be held to be unenforceable or invalid, the remaining parts thereof will nevertheless continue to be valid and enforceable
as though the invalid portion or portions were not a part hereof. If any of the provisions of Section 4 relating to
the scope of restrictions, periods of time or geographic area of restriction will be deemed to exceed the scope of restrictions,
maximum periods of time or area which a court of competent jurisdiction would deem enforceable, the scope of restrictions, time
and area will, for purposes of Section 4, be deemed to be the maximum scope, time periods and area which a court of
competent jurisdiction would deem valid and enforceable. If any other paragraph or subparagraph of this Agreement will be unenforceable
under any applicable law, the remainder of this Agreement will remain in full force and effect. Except as specifically provided
herein, nothing in this Agreement is intended to modify any existing agreements between the Company and Executive with regard to
the matters in Section 4.

 

		7.4	Waiver. If either party should waive
any breach of any provisions of this Agreement, such party will not thereby be deemed to have waived any preceding or succeeding
breach of the same or any other provision of this Agreement. It is agreed that no delay or omission to exercise any right, power
or remedy accruing to either party, upon any breach, default or noncompliance by the other party under this Agreement will impair
any such right, power or remedy, nor will it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence
therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit,
consent or approval of any kind or character on either party’s part of any breach, default or noncompliance under this Agreement
or any waiver on such party’s part of any provisions or conditions of the Agreement must be in writing and will be effective
only to the extent specifically set forth in such writing. All remedies, either under this Agreement by law, or otherwise afforded
to either party, will be cumulative and not alternative.

 

		7.5	Withholding. All amounts payable hereunder
will be reduced by any and all federal, state, and local taxes imposed upon the Executive that are required to be paid or withheld
by the Company.

 

     

     

    

 

		7.6	Complete Agreement. This Agreement,
your offer letter and the Confidentiality and Non-Compete Agreement constitute the entire agreement between Executive and the Company
with regard to the subject matter hereof. These agreements are the complete, final, and exclusive embodiment of the parties’
agreement with regard to this subject matter and supersede any prior oral discussions or written communications and agreements,
including but not limited to any previous agreements. In the event of a conflict between this Agreement, the offer letter or the
Confidentiality and Non-Compete Agreement, the provisions of this Agreement will control. This Agreement is entered into without
reliance on any promise or representation other than those expressly contained herein, and it cannot be modified or amended except
in writing signed by Executive and an authorized officer of the Company. The parties may enter into separate agreement(s) related
to stock options, stock awards or other matters relative to Executive’s service with the Company or its affiliates. These
separate agreements govern (or may govern) other aspects of the relationship between the parties, have or may have provisions that
survive termination of Executive’s employment under this Agreement, may be amended or superseded by the parties without regard
to this Agreement and are enforceable according to their terms without regard to the enforcement provision of this Agreement.

 

		7.7	Counterparts. This Agreement may be
executed in separate counterparts, including facsimile, PDF, or other electronic counterparts, any one of which need not contain
signatures of more than one party, but all of which taken together will constitute one and the same Agreement.

 

		7.8	Headings. The headings of the sections
hereof are inserted for convenience only and will not be deemed to constitute a part hereof nor to affect the meaning thereof.

 

		7.9	Successors and Assigns. The Company
may assign this Agreement and its rights and obligations hereunder in whole, but not in part, to any company or other entity with
or into which the Company may hereafter merge, consolidate, or be acquired by, or to which the Company may transfer all or substantially
all of its assets. Executive may not assign or transfer this Agreement or any rights or obligations hereunder, other than to Executive’s
estate upon Executive’s death.

 

		7.10	Choice of Law / Venue. All questions
concerning the construction, validity and interpretation of this Agreement will be governed by the internal, substantive laws of
the State of Colorado, as applied to agreements made and to be performed solely within the State of Colorado and without regard
to the principles of conflicts of laws of the State of Colorado or of any other jurisdiction that would result in the application
of the laws of any other jurisdiction to this Agreement. Any action brought to enforce this Agreement will be brought in Colorado
in a court of competent jurisdiction.

 

		7.11	Attorneys’ Fees. In any
action brought to enforce this Agreement, the substantially prevailing party in such dispute will be entitled to recover from the
losing party all reasonable fees, costs and expenses of enforcing any right of such substantially prevailing party under or with
respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys, which will include, without
limitation, all fees, costs and expenses of appeal.

 

     

     

    

 

In
Witness Whereof, the parties have executed this Agreement on the day and year first written above.

 

Company:

 

Zynex, Inc.

 

 

	By: 	/s/Thomas Sandgaard	 
	Title:  President & CEO

 

 

	Executive: Anna Lucsok
	 
	 
	/s/ Anna Lucsok	 

 

	

[Signature Page to Employment Agreement]Exhibit 4.1

 

DESCRIPTION
OF CAPITAL STOCK

The following is
a description of each class of securities of Silver Bull Resources, Inc. (“Silver Bull” or the “Company”)
that is registered under Section 12 of the Securities Exchange Act of 1934, as amended, and does not purport to be complete.
For a complete description of the terms and provisions of such securities, refer to the Company’s restated articles of incorporation,
as amended, and the Company’s bylaws, which are incorporated herein by reference to Exhibit 3.1.1 to the Company’s
Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on January 14, 2011,
Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 26, 2011, Exhibit 3.1
to the Company’s Current Report on Form 8-K filed with the SEC on September 18, 2020, and Exhibit 3.1.2 to
the Company’s Annual Report on Form 10-K filed with the SEC on January 14, 2011, respectively. This summary is
qualified in its entirety by reference to these documents.

Common Stock

Silver Bull’s
restated articles of incorporation, as amended, authorize Silver Bull to issue 37,500,000 shares of common stock, $0.01 par value
per share. As of January 28, 2021, 33,484,945 shares of Silver Bull common stock were issued and outstanding. The rights of
the holders of Silver Bull common stock are governed by Chapter 78 of the Nevada Revised Statutes, Silver Bull’s articles
of incorporation and Silver Bull’s bylaws.

Dividend Rights

Holders of Silver
Bull common stock will be entitled to receive dividends when, as and if declared by the Company’s board of directors, and
out of funds legally available for their payment. At the present time, the Company does not anticipate paying dividends, cash or
otherwise, on Silver Bull common stock in the foreseeable future. Future dividends will depend on the Company’s earnings,
if any, the Company’s financial requirements and other factors.

Redemption Rights

Silver Bull common
stock is not redeemable or convertible.

Voting Rights

Each holder of Silver
Bull common stock is entitled to one vote per share, and all voting rights are vested in the holders of shares of Silver Bull common
stock. Holders of shares of common stock will have noncumulative voting rights, which means that the holders of more than 50% of
the shares voting for the election of directors will be able to elect 100% of the directors, and the holders of the remaining shares
voting for the election of directors will not be able to elect any directors.

Election of Directors

The Company’s
directors are elected by a majority vote in a meeting at which a quorum is present. A director candidate that receives a majority
of the votes in favor of such candidate will be elected to serve on the Company’s board of directors.

In February 2016,
the Company’s board of directors adopted a majority voting policy stipulating that stockholders shall be entitled to vote
in favor of, or withhold from voting for, each individual director nominee at a stockholders’ meeting. If the number of shares
“withheld” for any nominee exceeds the number of shares voted “for” such nominee, then, notwithstanding
that such director was duly elected as a matter of corporate law, he or she shall tender his or her written resignation to the
chair of the board. The Corporate Governance and Nominating Committee will consider such offer of resignation and will make a recommendation
to the board of directors concerning the acceptance or rejection of the resignation after considering, among other things, the
stated reasons, if any, why certain stockholders “withheld” votes for the director, the qualifications of the director
and whether the director’s resignation from the board would be in the best interests of the Company. The board of directors
must take formal action on the Corporate Governance and Nominating Committee’s recommendation within 90 days and announce
its decision by a press release. According to the majority voting policy, the affected director cannot participate in the deliberations
of the Corporate Governance and Nominating Committee or the board of directors regarding his or her resignation. The majority voting
policy applies only in circumstances involving an uncontested election of directors, meaning an election in which the number of
nominees is equal to the number of directors to be elected.

 

    	  

    	 

    

 

Liquidation Rights

In the event of
the Company’s voluntary or involuntary liquidation, dissolution or winding up, the holders of Silver Bull common stock will
be entitled to share equally in any of Silver Bull’s assets available for distribution after the payment in full of all debts
and distributions.

No Preemptive or Similar Rights

Under Nevada law,
a stockholder of a corporation does not have a preemptive right to acquire the corporation’s unissued shares unless there
is a provision to the contrary in the articles of incorporation. The Company’s articles of incorporation do not provide the
Company’s stockholders with any preemptive or similar rights.

Transfer Agent

The transfer agent
and registrar for Silver Bull common stock is Equiniti Trust Company, located at 1110 Centre Pointe Curve, Suite 101, Mendota Heights,
Minnesota 55120-4100.

Warrants

As of January 28,
2021, the Company had issued and outstanding warrants to purchase 1,971,289 shares of common stock as follows:

		·	Warrants to purchase 1,811,789 shares at $0.59 per share, exercisable
on October 27, 2020 and expiring on October 27, 2025; and

		·	Warrants to purchase 159,500 shares at $0.59 per share, exercisable
on November 9, 2020 and expiring on November 9, 2025.

The number of shares
of Silver Bull common stock to be received upon the exercise of each warrant may be adjusted from time to time upon the occurrence
of certain events, including but not limited to (i) a declaration of a dividend or other distribution in respect of Silver
Bull common stock; (ii) a subdivision, redivision or change to the outstanding shares of Silver Bull common stock into a greater
number of shares of Silver Bull common stock; (iii) a reduction, combination or consolidation of Silver Bull common stock
into a lesser number of shares of Silver Bull common stock; (iv) a rights offering to subscribe for or purchase Silver Bull
common stock or securities convertible into or exchangeable for Silver Bull common stock; and (v) a reorganization, reclassification,
consolidation, amalgamation, arrangement or merger of the Company with or into any other corporation or entity, or a sale, lease,
exchange or transfer of substantially all of the undertaking of assets of the Company, or similar event.

Anti-Takeover Provisions in the Company’s
Articles of Incorporation and Bylaws

The Company’s
articles of incorporation and bylaws also contain provisions that the Company describes in the following paragraphs, which may
delay, defer, discourage, or prevent a change in control of the Company, the removal of the Company’s existing management
or directors, or an offer by a potential acquirer to the Company’s stockholders, including an offer by a potential acquirer
at a price higher than the market price for the stockholders’ shares.

Among other things,
Silver Bull’s articles of incorporation and bylaws:

		·	provide that vacancies on the board of directors may be filled by
the vote of a two-thirds (2/3) majority of the directors then in office or in the case of a vacancy by resignation or death, by
the majority of directors then in office;

		·	establish advance notice procedures with regard to stockholder proposals
relating to the nomination of candidates for election as directors or new business to be brought before meetings of the Company’s
stockholders. These procedures provide that notice of stockholder proposals must be timely given in writing to the Company’s
corporate secretary prior to the meeting at which the action is to be taken. Generally, to be timely, notice must be received at
the Company’s principal executive offices not less than 120 days prior to the first anniversary of the prior year’s
annual meeting (or, in the case of a special meeting, a reasonable time before the Company begins to print and send its proxy materials).
The Company’s bylaws specify the information that must be included in a stockholder’s notice. These requirements may
prevent stockholders from bringing matters before the stockholders at an annual or special meeting;

		·	provide that stockholders may not act by written consent in lieu
of a meeting;

 

    	  

    	 

    

 

 

		·	provide that stockholders are not permitted to call special meetings
of stockholders. Only the board of directors, by a two-thirds (2/3) majority vote, and the Company’s president are permitted
to call a special meeting of stockholders; and

		·	provide that the Company’s board of directors, by a two-thirds
(2/3) majority vote, may amend or repeal the Company’s bylaws without further stockholder approval unless otherwise required
by law, and provide that a stockholder amendment to the bylaws requires a favorable vote of sixty-six and two-thirds percent (66
2/3%) of the Company’s outstanding voting shares then entitled to vote at an election of directors.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]